[an error occurred while processing this directive]
Reviews

Research in metagenomics and its applications in translational medicine

Expand
  • Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266101, China

Received date: 2014-12-15

  Revised date: 2015-04-01

  Online published: 2015-07-20

Abstract

Humans are born with microbiota, which have accompanied us through our life-span. There is an important symbiotic relationship between us and the microbial communities, thus microbial communities are of great importance to our health. All genomic information within this microbiota is referered to as “metagenomics” (also referred to as “human’s second genome”). The analysis of high throughput metagenomic data generated from biomedical experiments would provide new approaches for translational research, and it have several applications in clinics. With the help of next generation sequencing technology and the emerging metagenomic approach (analysis of all genomic information in microbiota as a whole), we can overcome the pitfalls of tedious traditional method of isolation and cultivation of single microbial species. The metagenomic approach can also help us to analyze the whole microbial community efficiently and offer deep insights in human-microbe relationships as well as new ideas on many biomedical problems. In this review, we summarize frontiers in metagenomic research, including new concepts and methods. Then, we focus on the applications of metagenomic research in medical researches and clinical applications in recent years, which would clearly show the importance of metagenomic research in the field of translational medicine.

Cite this article

Jiahuan Chen, Zheng Sun, Xiaojun Wang, Xiaoquan Su, Kang Ning . Research in metagenomics and its applications in translational medicine[J]. Hereditas(Beijing), 2015 , 37(7) : 645 -654 . DOI: 10.16288/j.yczz.14-444

References

[1] Schrenk MO, Kelley DS, Delaney JR, Baross JA. Incidence and diversity of microorganisms within the walls of an active deep-sea sulfide chimney . Appl Environ Microbiol , 2003, 69(6): 3580-3592.
[2] Zeglin LH, Sinsabaugh RL, Barrett JE, Gooseff MN, Takacs-Vesbach CD. Landscape distribution of microbial activity in the mcmurdo dry valleys: linked biotic processes, hydrology, and geochemistry in a cold desert ecosystem . Ecosystems , 2009, 12(4): 562-573.
[3] Savage DC. Microbial ecology of the gastrointestinal tract . Annu Rev Microbiol , 1977, 31: 107-133.
[4] Berg RD. The indigenous gastrointestinal microflora . Trends Microbiol , 1996, 4(11): 430-435.
[5] Handelsman J, Rondon MR, Brady SF, Clardy J, Goodman RM. Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products . Chem Biol , 1998, 5(10): R245-249.
[6] Furrie E. A molecular revolution in the study of intestinal microflora . Gut , 2006, 55(2): 141-143.
[7] Wooley JC, Godzik A, Friedberg I. A primer on metagenomics . PLoS Comput Biol , 2010, 6(2): e1000667.
[8] Qin JJ, Li RQ, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li JH, Xu JM, Li SC, Li DF, Cao JJ, Wang B, Liang HQ, Zheng HS, Xie YL, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu HM, Yu C, Li ST, Jian M, Zhou Y, Li YR, Zhang XQ, Li SG, Qin N, Yang HM, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Meta HITC, Bork P, Ehrlich SD, Wang J. A human gut microbial gene catalogue established by metagenomic sequencing . Nature , 2010, 464(7285): 59-65.
[9] Lorenz P, Eck J. Metagenomics and industrial applications . Nat Rev Microbiol , 2005, 3(6): 510-516.
[10] Hernández-Reyes C, Schenk ST, Neumann C, Kogel KH, Schikora A. N -acyl-homoserine lactones-producing bacteria protect plants against plant and human pathogens . Microb Biotechnol , 2014, 7(6): 580-588.
[11] Kwak DS, Jun DW, Seo JG, Chung WS, Park SE, Lee KN, Khalid-Saeed W, Lee HL, Lee OY, Yoon BC, Choi HS. Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease . Eur J Gastroenterol Hepatol , 2014, 26(12): 1353-1359.
[12] Murtaza N, Baboota RK, Jagtap S, Singh DP, Khare P, Sarma SM, Podili K, Alagesan S, Chandra TS, Bhutani KK, Boparai RK, Bishnoi M, Kondepudi KK. Finger millet bran supplementation alleviates obesity-induced oxidative stress, inflammation and gut microbial derangements in high-fat diet-fed mice . Br J Nutr , 2014, 112(9): 1447-1458.
[13] Cénit MC, Matzaraki V, Tigchelaar EF, Zhernakova A. Rapidly expanding knowledge on the role of the gut microbiome in health and disease . Biochim Biophys Acta , 2014, 1842(10): 1981-1992.
[14] Song SJ, Lauber C, Costello EK, Lozupone CA, Humphrey G, Berg-Lyons D, Caporaso JG, Knights D, Clemente JC, Nakielny S, Gordon JI, Fierer N, Knight R. Cohabiting family members share microbiota with one another and with their dogs . Elife , 2013, 2: e00458.
[15] Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease . Curr Opin Gastroenterol , 2015, 31(1): 69-75.
[16] Dunne JL, Triplett EW, Gevers D, Xavier R, Insel R, Danska J, Atkinson MA. The intestinal microbiome in type 1 diabetes . Clin Exp Immunol , 2014, 177(1): 30-37.
[17] Kondrashova A, Hyöty H. Role of viruses and other microbes in the pathogenesis of type 1 diabetes . Int Rev Immunol , 2014, 33(4): 284-295.
[18] Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, Hardt PD. Microbiota and SCFA in lean and overweight healthy subjects . Obesity , 2010, 18(1): 190-195.
[19] Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit
Outlines

/